Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Lamisil AT Cream Terbinafine Hydrochloride 1 g/100g Cream — NDC 84485-3748-3 (Billing 84485-3748-03)
by Karo Healthcare Inc. · 1 TUBE in 1 CARTON / 30 g in 1 TUBE
This is a package of Lamisil AT Cream Terbinafine Hydrochloride 1 g/100g Cream from Karo Healthcare Inc., marketed since Nov 2024 and currently FDA-listed. It is this product's only package size.
NDC 84485-3748-03
🏷️ FDA NDC (as labeled)
84485-3748-3
billing pads the package segment with a zero
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
84485-3748-3
Product NDC
84485-3748
11-digit billing NDC
84485374803
UNII
012C11ZU6G
Application #
NDA020980
SPL Set ID
7f8434c2-60c9-4aeb-b0b8-f69107e74609
Established class (EPC)
Allylamine Antifungal
Chemical class
Allylamine
DEA schedule
Non-controlled
Marketing category
NDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2024-11-01
Route
TOPICAL
Dosage form
CREAM
Substance
TERBINAFINE HYDROCHLORIDE
Quick answers
- RxCUI (RxNorm): 992528
Why two NDCs?
The FDA registers this code as 84485-3748-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 84485-3748-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Allylamine Antifungal class.
Pharmacologic class
Allylamine Antifungal
Drug family (ATC)
Other antifungals for topical use, Antifungals for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
📗 Our plain-language guide HelloPharmacist
- It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doct...
- You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which t...
- Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor rig...
- Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading r...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
💬 Questions about Terbinafine Hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 84485-3748-03 You're viewing this Main listing | 1 TUBE in 1 CARTON / 30 g in 1 TUBE | 2024-11-01 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Neighbor Pharmacy 1 g/100g 24385-0524-03 | AmerisourceBergen | 1 tube | $0.231 | — | Availability likely | — |
| Terbinafine Hydrochloride 1 g/100g 70677-1003-01 | STRATEGIC | 1 tube | $0.309 | — | Availability likely | — |
| Terbinafine Hydrochloride 1 g/100g 51672-2080-01 | Sun | 1 tube | $0.398 | — | Availability likely | — |
| Terbinafine Hydrochloride 1 g/100g 70000-0338-01 | Cardinal | 1 tube | $0.398 | — | Availability likely | — |
| Walgreens Athletes Foot 1 g/100g 00363-2080-01 | Walgreen | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 00363-4502-02 | WALGREEN | 1 tube | — | — | FDA listed | — |
| Athletes Foot 1 g/100g 11822-0080-01 | Rite | 1 tube | — | — | FDA listed | — |
| Kroger Antifungal 1 g/100g 30142-0080-01 | Kroger | 1 tube | — | — | FDA listed | — |
| Athletes Foot 1 g/100g 37808-0080-01 | H | 1 tube | — | — | FDA listed | — |
| Antifungal 1 g/100g 41250-0080-02 | Meijer | 1 tube | — | — | FDA listed | — |
| equate Athletes Foot 1 g/100g 49035-0080-03 | Wal-Mart | 1 tube | — | — | FDA listed | — |
| Silka Antifungal 1 g/100g 50066-0080-02 | Genomma | 1 tube | — | — | FDA listed | — |
| Silka Jock Itch 1 g/100g 50066-0208-05 | Genomma | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 50090-1278-00 | A-S | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 50090-5810-00 | A-S | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 51672-2140-01 | Sun | 1 tube | — | — | FDA listed | — |
| Athletes Foot 1 g/100g 56062-0080-02 | Publix | 1 tube | — | — | FDA listed | — |
| CVS Pharmacy Athletes Foot 1 g/100g 59779-0080-01 | CVS | 1 tube | — | — | FDA listed | — |
| Cvs 1 g/100g 59779-0523-01 | CVS | 1 tube | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 61047-0120-01 | Voyant | 1 tube | — | — | Discontinued | — |
| Lamisil At Terbinafine Hydrochloride 1 g/100g 61047-0139-01 | Voyant | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 63187-0111-15 | Proficient | 1 tube | — | — | FDA listed | — |
| Good Neighbor Pharmacy 1 g/100g 68788-4044-01 | Preferred | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 68788-9814-01 | Preferred | 15 g | — | — | FDA listed | — |
| Curist Antifungal Relief 1 g/100g 72559-0035-58 | Little | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 73469-7215-02 | Scholl's | 1 tube | — | — | FDA listed | — |
| PHARMBANNER TINEA VERSICOLOR Cream 1 g/100g 83818-0024-01 | Shenzhen | 60 g | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 84485-3607-01 | Karo | 1 tube | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100gthis 84485-3748-03 | Karo | 1 tube | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 84485-4030-01 | Karo | 1 tube | — | — | FDA listed | — |
| Athlete Foot Cream 1 g/100g 85398-0006-01 | Beautivity | 60 g | — | — | FDA listed | — |
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2024
On the market since
Nov 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII LKG8494WBH
Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
-
UNII 936JST6JCN
Cetyl alcohol is a waxy, fatty substance derived from plant or animal sources. It acts as an emulsifier and thickener in medicines, helping blend oil and water components and giving products a smooth, creamy texture.
-
UNII 5ZA2S6B08X
Cetyl palmitate is a waxy substance made from natural fats. It works as a binder and thickener to help hold the medicine together and control how it dissolves in your body.
-
UNII 0RE8K4LNJS
Isopropyl myristate is an oily liquid made from coconut or palm oil. It's used in medicines as an emollient and penetration enhancer to help the medicine absorb through skin or improve spreadability in topical products.
-
UNII CAL22UVI4M
A synthetic emulsifier derived from sorbitol and fatty acids. It helps mix oil and water-based ingredients together and improves the texture and stability of the medicine.
-
UNII 55X04QC32I
A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
-
UNII NVZ4I0H58X
A waxy substance made from sorbitol and stearic acid. It acts as an emulsifier and stabilizer, helping keep oil and water mixed together and preventing separation in the medicine.
-
UNII 2KR89I4H1Y
Stearyl alcohol is a waxy, fatty substance derived from natural oils or made synthetically. It acts as an emulsifier and thickener in medicines, helping mix ingredients together and give the product the right texture.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
9 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesbenzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerKaro Healthcare Inc.
Application holderKARO HEALTHCARE INC
FDA applicationNDA020980 (NDA)
Labeler code84485
First marketedNov 2024
Product typeHuman Otc Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Other Information
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses cures most athlete's foot (tinea pedis) cures most jock itch (tinea cruris) and ringworm (tinea corporis) relieves itching, burning, cracking and scaling which accompany these conditions
⏱️ Dosage and Administration ▾
Directions adults and children 12 years and over: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor wash hands after each use children under 12 years: ask a doctor
⚠️ Warnings ▾
Warnings For external use only Do not use on nails or scalp in or near the mouth or eyes for vaginal yeast infections When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water. Stop use and ask a doctor if too much irritation occurs or gets worse Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active Ingredient Terbinafine hydrochloride 1% Purpose Antifungal
🧪 Inactive Ingredients ▾
Inactive Ingredients benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol
🎯 Purpose ▾
Purpose Antifungal
📄 Do Not Use ▾
Do not use on nails or scalp in or near the mouth or eyes for vaginal yeast infections
📄 When Using This Product ▾
When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if too much irritation occurs or gets worse
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Other Information ▾
Other Information do no use if seal on tube is broken or is not visible store at controlled room temperature 20-25°C (68-77°F)
📄 Questions or Comments ▾
Questions or comments? call 1-888-544-1880
📄 Package Label / Principal Display Panel ▾
PACKAGE LABEL.PRINCIPAL DISPLAY LAMISIL AT CREAM TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL FOR ATHLETE'S FOOT ► RELIEVES ITCHING ► CLINICALLY PROVEN TO CURE MOST ATHLETE’S FOOT BETWEEN THE TOES ► FULL PRESCRIPTION STRENGTH NET WT 30 g (1 oz) RECYCLABLE CARTON Distributed by: Karo Healthcare Inc. Morristown, NJ 07960 USA Made in Canada Trademarks owned or licensed by Karo Healthcare ©2024 Karo Healthcare or licensor. 1-888-544-1880 NDC 84485-3748-3 2004439_1 2003665_1 LAMISIL AT CREAM TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL FOR ATHLETE'S FOOT NET WT 30g (1 oz) 2004440_1
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Lamisil AT Cream (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 48%
Female · 51%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Karo Healthcare Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Karo Healthcare Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.